United States · 
What does BioStar Ventures invest in?
BioStar Ventures invests most often at Series B and Series C (70% of the rounds on record), in sectors such as E-Commerce, Financial Services and Medical Device.
BioStar Ventures highlights
- 01
20 rounds on record
- 02
Mostly Series B and Series C: 70% of its rounds
- 03
Sole investor in 1 rounds, median $5.3M
- 04
2 exits from the portfolio
What they do
Filed 1 private fund offerings with the SEC, the most recent in 2025-09From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Growth
- Sectors
- E-CommerceFinancial ServicesMedical Device
- Based in
- United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first20 appearances
- 2019
1 round
- Jan
- 2016
1 round
- Jul
- 2014
5 rounds
- Dec
- Oct
- Jul
- Mar
- Feb
- 2013
3 rounds
- Nov
- Jan
- Jan
- 2012
3 rounds
- Dec
- Jun
- May
- 2011
2 rounds
- Oct
- Aug
- 2010
1 round
- Apr
- 2009
1 round
- Oct
- 2006
3 rounds
- Dec
- Nov
- Oct
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration7 named
JAJeffrey A. O'DonnellManaging Director of the General PartneriFiling they signed
LALouis A. CannonSENIOR MANAGING DIRECTOR OF THE GENERAL PARTNERiFiling they signed
LALouis A. Cannon, M.D.SENIOR MANAGING DIRECTOR OF THE MANAGERiFiling they signed
MAMichael A. FultonMANAGING DIRECTOR OF THE GENERAL PARTNERiFiling they signed
PAPaul A. ScottMANAGING DIRECTOR OF THE GENERAL PARTNERiFiling they signed
RARenee A. MasiManaging Director of the General PartneriFiling they signed
SASteven A. AlmanySenior Managing Director of the General PartneriFiling they signed
We also hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
1 of 7 we have independently watched raise
Transcatheter renal denervationBioresorbable polymer technologiesEndovascular therapy forINVESTOR PORTALPulsed field ablationRobotic microsurgery usingSimple, percutaneous tricuspid
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
Reverse MedicalBought by CovidienUndisclosedAug 2014
AorTxBought by Hansen Medical$9.3MNov 2007
An exit counts when it came after the firm's first round in the company. From historical deal records.